WO2022172057A1 - Nanoin inhaler - Google Patents

Nanoin inhaler Download PDF

Info

Publication number
WO2022172057A1
WO2022172057A1 PCT/IB2021/051122 IB2021051122W WO2022172057A1 WO 2022172057 A1 WO2022172057 A1 WO 2022172057A1 IB 2021051122 W IB2021051122 W IB 2021051122W WO 2022172057 A1 WO2022172057 A1 WO 2022172057A1
Authority
WO
WIPO (PCT)
Prior art keywords
inhaler
sensors
button
patient
flow rate
Prior art date
Application number
PCT/IB2021/051122
Other languages
French (fr)
Inventor
Mojgan MOZAFARI
Leila MASHAYEKHI
Mohammadreza HEMMATIAN
Erfaneh KHAKZADGHOMI
Hadavi SHAHNAZ
Original Assignee
Mozafari Mojgan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mozafari Mojgan filed Critical Mozafari Mojgan
Priority to PCT/IB2021/051122 priority Critical patent/WO2022172057A1/en
Publication of WO2022172057A1 publication Critical patent/WO2022172057A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/08—Detecting, measuring or recording devices for evaluating the respiratory organs
    • A61B5/087—Measuring breath flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0015—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by features of the telemetry system
    • A61B5/0022—Monitoring a patient using a global network, e.g. telephone networks, internet
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/13—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered from dispensers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/67—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for remote operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018—Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003—Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/003—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter
    • A61M2016/0033—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical
    • A61M2016/0039—Accessories therefor, e.g. sensors, vibrators, negative pressure with a flowmeter electrical in the inspiratory circuit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/27—General characteristics of the apparatus preventing use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3546—Range
    • A61M2205/3561—Range local, e.g. within room or hospital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/35—Communication
    • A61M2205/3576—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver
    • A61M2205/3592—Communication with non implanted data transmission devices, e.g. using external transmitter or receiver using telemetric means, e.g. radio or optical transmission
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A61M2205/505—Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/82—Internal energy supply devices
    • A61M2205/8237—Charging means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/04—Heartbeat characteristics, e.g. ECG, blood pressure modulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2230/00—Measuring parameters of the user
    • A61M2230/08—Other bio-electrical signals
    • A61M2230/10—Electroencephalographic signals

Definitions

  • the invention relates to respiratory issues (such as asthma, or COPD), medication adherence, and patient-doctor relationships, to be more specific, this invention pertains to smart inhalers using nanotechnology - nanoaerosol, and cloud-based system.
  • BIOMETRIC CONTROLLED SMART INHALERS has been published in the PCT with the application number PCT / US2020 / 037242, which enclose the invention in that field.
  • the invention provides a device comprising: a biometric reader, capable of detecting an abnormal condition; and an inhaler unit capable of delivering a drug to an airway of a subject, wherein said biometric reader is operably linked to said inhaler unit, and wherein said inhaler unit delivers said drug to said airway in said subject in response to said biometric reader’s detection of the abnormal condition in said subject.
  • the device comprises a first handgrip and a second handgrip, wherein each the first and second grips comprises an electrode of said biometric reader.
  • the device comprises an interlocking mechanism, said mechanism is capable of blocking or stopping the activation of the delivery of the drug by said inhaler unit until the detection of said abnormal condition by said biometric reader.
  • the biometric reader is an electrocardiogram (ECG) unit and the abnormal condition is a heart disease or condition, such as supraventricular tachycardia (SVT).
  • the drug is any suitable drug for treating SVT, for example, verapamil.
  • the biometric reader is an electroencephalogram (EEG) unit and the abnormal condition is a condition associated with epilepsy.
  • the drug is any suitable drug for treating epilepsy, for example, carbamazepine, phenytoin, or valproic acid.
  • the loT, cloud-based clamed device has sensors that act as a clip on extension to existing inhalers. It has a GPS extension which allows it to track when and where the puffs are taken by the patients. These sensors are linked with an application that the patient must install on their smartphone. This information is relayed to the application by the sensors via bluetooth, or a plug-in hub. These are often used as a part of the disease's management program, under a physician's regulation. It is a digital platform consisting of a custom sensor which records and transmits the treatment acquiescence data.
  • the inhaler platform enables physicians to effectively monitor the inhalation technique and frequency, capturing factors such as inhalation flow rate, flow speeding, inhalation volume, stimulus time, and patient's usage of the inhaler.
  • the data that is generated by the app is an important tool which offers the user simple metrics and tailored advice for a more real supervision of their condition.
  • loT based inhaler helps the patients adhere to their medication routine, and also allows the physicians to monitor their patients remotely.
  • the inhaler by exact controlling doses, precisely stores data usage in the cloud when each dose is taken, it transfers this status to doctors, and helps keep the illnesses at check. This technology also gives automatically generated reminders, through the app, informing the patient to use the inhaler whenever necessary. Identification of the patient's inhaler usage pattern will aid patients as well as doctors in getting a better understanding of respiratory diseases and how it affects the body. This makes the patient aware of the triggers, like flower pollen or temperature and helps keep them well-informed which helps to avoid asthma attacks and other diseases, preventing hospitalization. [0015]
  • the GPS sensor of the inhaler is a unique feature which actively records where and when the puff was taken, with this data over a period of time, it comes up with a pattern, without any necessity of personal diaries or other conscious entry of information.
  • the time and location data for each use is linked with a wide range of factors from environmental, geographic, traffic, and numerous neighbourhood data.
  • Nanoln is a smart nanoaerosol inhaler that utilizes a cloud-based data system. It is a smart inhaler that is equipped with sensors that automatically send usage data to its' user's doctor; who can then provide feedback through our mobile application, which is available on all iOS and Android devices.
  • This invention does not have a biometric reader, but measures dosage and use of the inhaler to send data to the app. It does not send recommendations based on biometric feedback like the example sent but simply monitors use which connects to the app.
  • the innovation is that it is a smart nanoaerosol inhaler.
  • the main differentiator is that it monitors use and administers nanoaerosol medication.
  • This invention will use pressurized metered-dose method to administer nanoaerosol medications.
  • Figure 1 shows the location of the sensors
  • the spray button (1) acts as a Bluetooth box, GPS sensor and wireless connection.
  • the pair and reset button (2) is installed next to the device, which is used for wireless communication with the mobile phone. Below that is the USB-C port (3) for charging and connecting to the cable. Flow rate, speed, volume and time sensors are located on the edge (4) of the material output from the spray.
  • the inhaler platform enables physicians to effectively monitor the inhalation technique and frequency, capturing factors such as inhalation flow rate, flow speeding, inhalation volume, stimulus time, and patient's usage of the inhaler.
  • the data that is generated by the app is an important tool which offers the user simple metrics and tailored advice for a more real supervision of their condition.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)

Abstract

NanoIn is a smart nanoaerosol inhaler that utilizes a cloud-based data system. It is a smart inhaler that is equipped with sensors that automatically send usage data to its' user's doctor; who can then provide feedback through our mobile application, which is available on all iOS and Android devices.

Description

Description
Title of Invention : Nanoln Inhaler
Technical Field
[0001] The invention relates to respiratory issues (such as asthma, or COPD), medication adherence, and patient-doctor relationships, to be more specific, this invention pertains to smart inhalers using nanotechnology - nanoaerosol, and cloud-based system.
Background Art
[0002] An invention titled BIOMETRIC CONTROLLED SMART INHALERS has been published in the PCT with the application number PCT / US2020 / 037242, which enclose the invention in that field.
[0003] the invention provides a device comprising: a biometric reader, capable of detecting an abnormal condition; and an inhaler unit capable of delivering a drug to an airway of a subject, wherein said biometric reader is operably linked to said inhaler unit, and wherein said inhaler unit delivers said drug to said airway in said subject in response to said biometric reader’s detection of the abnormal condition in said subject. In some embodiments, the device comprises a first handgrip and a second handgrip, wherein each the first and second grips comprises an electrode of said biometric reader. In one embodiment, the device comprises an interlocking mechanism, said mechanism is capable of blocking or stopping the activation of the delivery of the drug by said inhaler unit until the detection of said abnormal condition by said biometric reader.
[0004] In one exemplary embodiment, the biometric reader is an electrocardiogram (ECG) unit and the abnormal condition is a heart disease or condition, such as supraventricular tachycardia (SVT). In one embodiment, the drug is any suitable drug for treating SVT, for example, verapamil.
[0005] In another exemplary embodiment, the biometric reader is an electroencephalogram (EEG) unit and the abnormal condition is a condition associated with epilepsy. In one embodiment, the drug is any suitable drug for treating epilepsy, for example, carbamazepine, phenytoin, or valproic acid. [0006] The application method of the claimed invention is different from this invention.
Technical Problem
[0007] Almost 3 million Canadians are living with asthma, that equates to roughly 9.5% of the total population of Canada. Nearly three quarters of people with asthma have reported that they experience some form of health-related anxiety. This is largely due to the lack of support and uncertainty about their treatment plans. Canadians have a two in five chance of being diagnosed with asthma before the age of 40. Subsequently, 60% of individuals with asthma have poorly controlled disease, which can often restrict their daily activities and leave them with a poor quality of life.
[0008] This statistic can be seen in different countries with some changes. There are many other people who use inhalers or sprays on a daily basis, meaning that it is not uncommon that patients need to take them several times a day - or in emergency situations where breathing becomes strained or challenging. Any time an individual's breathing is compromised, it is very scary and can cause lots of stress and anxiety. In these moments, having an inhaler that one can have confidence in and rely on is essential. Even so, using an inhaler daily may sound daunting, and in reality, it really is.
[0009] Furthermore, medication adherence, including inhaler usage, poses a difficult challenge for patients; especially those in at-risk age groups. Parents of children who require inhalers may worry that their child is not sticking to their prescribed schedule and will not get the benefits of their medication or that they may have an adverse reaction without it. Similarly, the senior population is an at-risk group when it comes to medication adherence as well. Seniors are notorious for medication non-adherence; missing a dose, or even taking the incorrect dosage - all of which can be extremely dangerous and the prevalence of COPD has become a real concern. Our population is aging very quickly, and the prevalence of COPD is becoming a very real concern. Seniors must juggle so many prescriptions that they may forget their inhaler amidst all of their other daily pills.
[0010] Patients often feel as though once they are prescribed their medication, that the doctor's role in their treatment is over and they are left to handle everything on their own but this is not case. Improved relationships with physicians and patients have shown to improve treatment outcomes and increase medication adherence. Our aim is to not only provide access to the most state-of-the-art inhalers on the market but also to support patients after they receive their prescription to ensure they are well taken care of long term.
Solution to Problem
[0011] The loT, cloud-based clamed device has sensors that act as a clip on extension to existing inhalers. It has a GPS extension which allows it to track when and where the puffs are taken by the patients. These sensors are linked with an application that the patient must install on their smartphone. This information is relayed to the application by the sensors via bluetooth, or a plug-in hub. These are often used as a part of the disease's management program, under a physician's regulation. It is a digital platform consisting of a custom sensor which records and transmits the treatment acquiescence data.
[0012] The inhaler platform enables physicians to effectively monitor the inhalation technique and frequency, capturing factors such as inhalation flow rate, flow speeding, inhalation volume, stimulus time, and patient's usage of the inhaler.
The data that is generated by the app is an important tool which offers the user simple metrics and tailored advice for a more real supervision of their condition.
[0013] The key feature of the loT based inhaler is that it helps the patients adhere to their medication routine, and also allows the physicians to monitor their patients remotely.
[0014] The inhaler by exact controlling doses, precisely stores data usage in the cloud when each dose is taken, it transfers this status to doctors, and helps keep the illnesses at check. This technology also gives automatically generated reminders, through the app, informing the patient to use the inhaler whenever necessary. Identification of the patient's inhaler usage pattern will aid patients as well as doctors in getting a better understanding of respiratory diseases and how it affects the body. This makes the patient aware of the triggers, like flower pollen or temperature and helps keep them well-informed which helps to avoid asthma attacks and other diseases, preventing hospitalization. [0015] The GPS sensor of the inhaler is a unique feature which actively records where and when the puff was taken, with this data over a period of time, it comes up with a pattern, without any necessity of personal diaries or other conscious entry of information.
[0016] The time and location data for each use is linked with a wide range of factors from environmental, geographic, traffic, and numerous neighbourhood data.
[0017] Nanoln is a smart nanoaerosol inhaler that utilizes a cloud-based data system. It is a smart inhaler that is equipped with sensors that automatically send usage data to its' user's doctor; who can then provide feedback through our mobile application, which is available on all iOS and Android devices.
[0018] This invention does not have a biometric reader, but measures dosage and use of the inhaler to send data to the app. It does not send recommendations based on biometric feedback like the example sent but simply monitors use which connects to the app.
[0019] The innovation is that it is a smart nanoaerosol inhaler. The main differentiator is that it monitors use and administers nanoaerosol medication. This invention will use pressurized metered-dose method to administer nanoaerosol medications.
Advantageous Effects of Invention
[0020] - Improved treatment for asthma or COPD
[0021] - Improved medical adherence
[0022] - Improved patient-doctor relationships
[0023] - Improved quality of life
[0024] - Better awareness of surroundings
[0025] - Better awareness of respiratory illness
[0026] - User convenience
[0027] - Technology-forward
[0028] - Connects to mobile device
Brief Description of Drawings [0029] Figure 1 : shows the location of the sensors
Description of Embodiments
[0030] The spray button (1) acts as a Bluetooth box, GPS sensor and wireless connection. The pair and reset button (2) is installed next to the device, which is used for wireless communication with the mobile phone. Below that is the USB-C port (3) for charging and connecting to the cable. Flow rate, speed, volume and time sensors are located on the edge (4) of the material output from the spray.
[0031] The inhaler platform enables physicians to effectively monitor the inhalation technique and frequency, capturing factors such as inhalation flow rate, flow speeding, inhalation volume, stimulus time, and patient's usage of the inhaler. The data that is generated by the app is an important tool which offers the user simple metrics and tailored advice for a more real supervision of their condition.

Claims

Claims
[Claim 1] A device for measuring user performance in using inhaler, which includes the following components: a. a. Bluetooth sensor, GPS and wireless connection b. b. Pair button and USB-C port c. c. Flow rate, speed, volume and time sensors
[Claim 2] A device that, according to claim 1 , the spray button acts as a Bluetooth box, GPS sensor and wireless connection and sends the information of using this button to the software.
[Claim 3] A device that, according to claim 1 , has a pair and reset button installed in the device, which is used for wireless communication with the mobile phone, and also a USB-C port (3) for charging and connection to the cable.
[Claim 4] A device according to claim 1 , flow rate, speed, volume and time sensors are installed at the edge (4) of the material output from the spray.
[Claim 5] A device that, according to claim 1 , collects all the information from the sensors and sends it to the server, and the physician can check the patient's performance by examining them and offer his suggestions to him for the optimal use of the device.
PCT/IB2021/051122 2021-02-11 2021-02-11 Nanoin inhaler WO2022172057A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2021/051122 WO2022172057A1 (en) 2021-02-11 2021-02-11 Nanoin inhaler

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2021/051122 WO2022172057A1 (en) 2021-02-11 2021-02-11 Nanoin inhaler

Publications (1)

Publication Number Publication Date
WO2022172057A1 true WO2022172057A1 (en) 2022-08-18

Family

ID=82838294

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2021/051122 WO2022172057A1 (en) 2021-02-11 2021-02-11 Nanoin inhaler

Country Status (1)

Country Link
WO (1) WO2022172057A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190027240A1 (en) * 2016-01-11 2019-01-24 Syqe Medical Ltd. Method and system for controlling the delivery of active agents
WO2020065621A1 (en) * 2018-09-27 2020-04-02 Breathesuite Inc. Accessories for inhalers
WO2020252169A1 (en) * 2019-06-11 2020-12-17 Alsar Ltd Partnership Biometric controlled smart inhalers

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190027240A1 (en) * 2016-01-11 2019-01-24 Syqe Medical Ltd. Method and system for controlling the delivery of active agents
WO2020065621A1 (en) * 2018-09-27 2020-04-02 Breathesuite Inc. Accessories for inhalers
WO2020252169A1 (en) * 2019-06-11 2020-12-17 Alsar Ltd Partnership Biometric controlled smart inhalers

Similar Documents

Publication Publication Date Title
US11367519B1 (en) Systems and methods for precision or personal pharmaceutical dosing
JP7040943B2 (en) Unlocking applications using connected physical devices and transferring data between them
JP6591409B2 (en) Patient care system to report treatment plan compliance status
US20190084737A1 (en) Systems, methods, and devices for dispensing one or more substances
CN113616883B (en) System for pulmonary delivery of at least one pharmacologically active agent in plant material to a subject
CN106573118B (en) Methods, devices, and systems for pulmonary delivery of active agents
JP2023062005A (en) medical evaluation device
EP3195160B1 (en) Computer controlled dosage system
JP2003511124A (en) Patient remote evaluation system
US10204213B2 (en) Methods and apparatus for monitoring and/or regulating medicament and medicament dispensation
CN114728134A (en) Interconnection of drug administration systems
US20210345954A1 (en) Monitoring and communicating information using drug administration devices
US20180369514A1 (en) Metered Dose Inhaler
US20210350896A1 (en) Patient monitoring using drug administration devices
CN116744987A (en) Aggregation and analysis of drug administration data
JP2022550330A (en) Medication delivery device communicating with external systems and/or other devices
JP2016513982A (en) System for monitoring disease status
US20210345952A1 (en) Controlling operation of drug administration devices using surgical hubs
CN114746951A (en) Remote aggregation of data for drug administration devices
WO2022172057A1 (en) Nanoin inhaler
WO2016196145A1 (en) Systems, methods, and devices for dispensing one or more substances
DE102020121044A9 (en) nasal applicator
US11950886B2 (en) Apparatus and method for providing remote health care recommendations using a passive health care monitoring device
EP4023276A1 (en) Nasal applicator
WO2022031698A1 (en) Inhaler and interface related thereto

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21925546

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21925546

Country of ref document: EP

Kind code of ref document: A1